CRL
Charles River Laboratories International, Inc.
Stock
$290.19+3.36 (+1.17%)Close Oct 2, 2026
- Shareholders' equity, 2025
- $3.2B
- YoY, 2025
- −8.6%
- 5-year CAGR
- +8.4%
- 10-year CAGR
- +15.7%
Shareholders' equity
Shareholders' equity by fiscal year
| Period | Equity | YoY |
|---|---|---|
| 2025 | $3.2B | −8.6% |
| 2024 | $3.5B | −3.8% |
| 2023 | $3.6B | +20.9% |
| 2022 | $3.0B | +17.4% |
| 2021 | $2.5B | +19.9% |
| 2020 | $2.1B | +29.4% |
| 2019 | $1.6B | +24.1% |
| 2018 | $1.3B | +26.1% |
| 2017 | $1.0B | +24.9% |
| 2016 | $837M | +14.1% |
| 2015 | $733M | +9.1% |
| 2014 | $672M | +4.9% |
| 2013 | $641M | +6.7% |
| 2012 | $601M | +14.3% |
| 2011 | $526M | −23.5% |
| 2010 | $687M | −50.0% |
| 2009 | $1.4B | +10.8% |
| 2008 | $1.2B | — |